DPYD and neoplasm: Possible mechanisms included suppression of NF-kB nuclear translocation and I-kB phosphorylation and dihydropyrimidine dehydrogenase (DPD) downregulation to slow down drug metabolism, which boosted the anti-tumor efficacy of low dose 5-Fu in MGC803 cells (137).